The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 339:469-471 August 13, 1998 Number 7
NextNext

Chemoprevention of Hereditary Ovarian Cancer

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Narod, S. A.
-PubMed Citation
Ovarian cancer is an insidious disease that kills more American women each year than all other gynecologic cancers combined. It causes no specific symptoms even when the disease is advanced, there are no effective screening tests, and risk factors for this type of cancer are not well defined. As a result, in most women, ovarian cancer is not diagnosed until extensive spread has occurred; despite the advances that have been made in the surgical and pharmacologic treatment of the disease, most women with this form of cancer die from it.

Among the suggested risk factors for ovarian cancer, which include . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.